z-logo
open-access-imgOpen Access
JAK3 inhibitor VI is a mutant specific inhibitor for epidermal growth factor receptor with the gatekeeper mutation T790M
Author(s) -
Naoyuki Nishiya,
Yasumitsu Sakamoto,
Yusuke Oku,
Takamasa aka,
Yoshimasa Uehara
Publication year - 2015
Publication title -
world journal of biological chemistry
Language(s) - English
Resource type - Journals
ISSN - 1949-8454
DOI - 10.4331/wjbc.v6.i4.409
Subject(s) - t790m , gefitinib , autophosphorylation , tyrosine kinase inhibitor , egfr inhibitors , tyrosine kinase , epidermal growth factor receptor , cancer research , kinase , microbiology and biotechnology , chemistry , biology , biochemistry , protein kinase a , signal transduction , receptor , cancer , genetics
To identify non-quinazoline kinase inhibitors effective against drug resistant mutants of epidermal growth factor receptor (EGFR).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here